Browsing Tag
Kowa Company
2 posts
Glaucoma drug NCX 470 reaches another major market as Nicox’s partner strategy pays off
NCX 470 enters China review as Nicox targets glaucoma royalties across China, the U.S. and Japan. See what the filing means for growth.
Lupin gains FDA approval for generic Pitavastatin Tablets, targeting $298m market
Global pharmaceutical giant Lupin Limited announced its receipt of approval from the United States Food and Drug Administration…